GU Cancers 2020 | Potential prognostic markers in sarcomatoid and rhabdoid RCC

Ziad Bakouny

Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the genomic characterization of sarcomatoid and rhabdoid renal cell carcinoma (RCC) to reveal potential markers of poor prognosis and response to immune checkpoint inhibition. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter